Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Type Strain
no
Preceptrol®
no
Comments
highly virulent for laboratory animals
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
Growth Conditions
Temperature: 24.0°C
Name of Depositor
Eli Lilly & Co.
Chain of Custody
ATCC <<--Eli Lilly & Co.<<--NIH B207
Isolation
clinical isolate
References
Turner JR, et al. A32390A, a new biologically active metabolite. III. In vitro and in vivo antifungal activity. J. Antibiot. 31: 33-37, 1978. PubMed: 342474
Turner JR, et al. Colonization of the intestinal tract of conventional mice with Candida albicans and treatment with antifungal agents. Antimicrob. Agents Chemother. 9: 787-792, 1976. PubMed: 782356
Debono M, et al. Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B. Ann. N.Y. Acad. Sci. 544: 152-167, 1988. PubMed: 3063167
Gordee RS, et al. In vitro and in vivo anti-Candida activity and toxicology of LY121019. J. Antibiot. 37: 1054-1065, 1984. PubMed: 6389460
